These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31787680)
1. [Animal models of synucleinopathies: prion-like propagation of alpha-synuclein in wild-type animals]. Masuda-Suzukake M Nihon Yakurigaku Zasshi; 2019; 154(6):301-305. PubMed ID: 31787680 [TBL] [Abstract][Full Text] [Related]
2. [Prion-like Propagation of Pathological α-Synuclein in Vivo]. Masuda-Suzukake M; Hasegawa M Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247 [TBL] [Abstract][Full Text] [Related]
3. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils. Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378 [TBL] [Abstract][Full Text] [Related]
4. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
5. Common Marmoset Model of α-Synuclein Propagation. Masuda-Suzukake M; Shimozawa A; Hashimoto M; Hasegawa M Methods Mol Biol; 2021; 2322():131-139. PubMed ID: 34043199 [TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications. Li A; Rastegar C; Mao X Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883550 [TBL] [Abstract][Full Text] [Related]
7. Pathological alpha-synuclein propagates through neural networks. Masuda-Suzukake M; Nonaka T; Hosokawa M; Kubo M; Shimozawa A; Akiyama H; Hasegawa M Acta Neuropathol Commun; 2014 Aug; 2():88. PubMed ID: 25095794 [TBL] [Abstract][Full Text] [Related]
8. Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts. Ayers JI; Riffe CJ; Sorrentino ZA; Diamond J; Fagerli E; Brooks M; Galaleldeen A; Hart PJ; Giasson BI J Virol; 2018 Sep; 92(18):. PubMed ID: 29976670 [TBL] [Abstract][Full Text] [Related]
9. Robust Central Nervous System Pathology in Transgenic Mice following Peripheral Injection of α-Synuclein Fibrils. Ayers JI; Brooks MM; Rutherford NJ; Howard JK; Sorrentino ZA; Riffe CJ; Giasson BI J Virol; 2017 Jan; 91(2):. PubMed ID: 27852849 [TBL] [Abstract][Full Text] [Related]
10. The effect of truncation on prion-like properties of α-synuclein. Terada M; Suzuki G; Nonaka T; Kametani F; Tamaoka A; Hasegawa M J Biol Chem; 2018 Sep; 293(36):13910-13920. PubMed ID: 30030380 [TBL] [Abstract][Full Text] [Related]
11. Prion-like spreading of pathological α-synuclein in brain. Masuda-Suzukake M; Nonaka T; Hosokawa M; Oikawa T; Arai T; Akiyama H; Mann DM; Hasegawa M Brain; 2013 Apr; 136(Pt 4):1128-38. PubMed ID: 23466394 [TBL] [Abstract][Full Text] [Related]
12. Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions. Tanriöver G; Bacioglu M; Schweighauser M; Mahler J; Wegenast-Braun BM; Skodras A; Obermüller U; Barth M; Kronenberg-Versteeg D; Nilsson KPR; Shimshek DR; Kahle PJ; Eisele YS; Jucker M Acta Neuropathol Commun; 2020 Aug; 8(1):133. PubMed ID: 32787922 [TBL] [Abstract][Full Text] [Related]
13. Prion-like propagation of α-synuclein in neurodegenerative diseases. Tarutani A; Hasegawa M Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325 [TBL] [Abstract][Full Text] [Related]
14. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease. Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614 [TBL] [Abstract][Full Text] [Related]
15. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice. Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930 [TBL] [Abstract][Full Text] [Related]
16. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy. Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276 [TBL] [Abstract][Full Text] [Related]
17. Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114. Quintin S; Lloyd GM; Paterno G; Xia Y; Sorrentino Z; Bell BM; Gorion KM; Lee EB; Prokop S; Giasson BI J Biol Chem; 2023 Jul; 299(7):104912. PubMed ID: 37307916 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice. Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344 [TBL] [Abstract][Full Text] [Related]
19. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity. Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728 [TBL] [Abstract][Full Text] [Related]